The new VivaDiag™ SARS-CoV-2 Ag Rapid Test

The new VivaDiag™ SARS-CoV-2 Ag Rapid Test is for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab,oropharyngeal swab or nasopharyngeal swab specimen. The test is for in vitro diagnostic use only.

Special features:

  • For nasal or throat swab samples
  • CE marked
  • Professional Use Only
  • High Sensitivity
  • Short Turnout Time
  • High Specificity

Test Principle: Colloidal gold
Sample Type: Nasal swab, oropharyngeal swab or nasopharyngeal swab
Sample Volume: 60 μL
Test Time: 15 min


VivaDiag™ SARS-CoV-2 Ag Rapid Test has ONLY been designed to act as a supplementary test for suspected cases of negative coronavirus nucleic acid detection or in conjunction with nucleic acid detection in the diagnosis of suspected cases. Results from nucleocapsid protein antigen testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 (COVID-19) infection or to inform infection status.


Send a Request

Webinar registration

Bestellen Sie jetzt

Webinar DE

Request for IDIS2GO

Antrag für IDIS2GO